Alcohol has a profound effect on sleep. However, neuronal substrates mediating sleep-promoting effects of alcohol are unknown. Since the basal forebrain (BF) cholinergic neurons are implicated in the homeostatic regulation of sleep, we hypothesized that the BF cholinergic neurons may have an important role in sleepiness observed after alcohol consumption. 192-IgG-saporin (bilateral BF infusions) was used to selectively lesion BF cholinergic neurons in adult male Sprague-Dawley rats. Standard surgical procedures were used to implant sleep recording electrodes or microdialysis guide cannulas. The first experiment used between-group design [lesion and sham (controls)] and examined effects of BF cholinergic neuronal lesions on alcohol (3 g/Kg; ig) induced sleep promotion. The second experiment used within-group design [lesion (ipsilateral BF) and sham (controls; contralateral BF) in same animal] and local reverse microdialysis infusion of alcohol (300 mM) to examine the effects of cholinergic neuronal lesions on extracellular adenosine in the BF. Alcohol had a robust sleep promoting effect in controls as evidenced by a significant reduction in sleep onset latency and wakefulness; non-rapid eye movement sleep was significantly increased. No such alcoholinduced sleep promotion was observed in lesioned rats with significantly fewer BF cholinergic neurons. Rapid eye movement sleep was minimally affected. Adenosine release was significantly reduced following local infusion of alcohol on the lesion side, with significantly fewer cholinergic neurons as compared with the control side. Based on these results, we suggest that alcohol promotes sleep by increasing extracellular adenosine via its action on cholinergic neurons of the BF.
Alcohol has a profound impact on sleep and is one of the most commonly used 'over the counter' sleep aid (Brower 2001; Roth 2001, 2012; Colrain et al. 2009 Colrain et al. , 2014 Ebrahim et al. 2013; Thakkar et al. 2015) . In healthy humans, acute alcohol intake decreases sleep latency; increases quality (increased delta power) and quantity of non-rapid eye movement (NREM) sleep especially during the first half of sleeping period. However, sleep is severely disrupted during the second half of sleep period (Roehrs and Roth 2001; Ebrahim et al. 2013) . In contrast, alcoholics, both during drinking period and during abstinence suffer from multitudes of sleep disturbances including insomnia, excessive daytime sleep, and altered sleep architecture (Brower 2001) . In fact, prevalence of sleep disturbances in alcoholics has been estimated to be > 80% (Foster and Peters 1999; Hartwell et al. 2015) . Furthermore, in recovering alcoholics, subjective and objective indicators of sleep disturbances are predictors of relapse (Brower and Perron 2010) . Finally, within the USA, it is estimated that the cost of alcohol-related problems exceeds $180 billion, out of which more than $18 billion is associated with alcohol associated sleep disorders (Brower 2001) . Thus, although alcohol associated sleep problems have significant economic and clinical consequences, very little is known about the neuronal substrates mediating the effects of alcohol on sleep.
Treatment of alcoholism requires proper management of withdrawal symptoms and prevention of relapse. Insomnia and associated sleep disruptions are severe and protracted symptoms and are predictors of relapse. Thus, it is imperative to understand the underlying mechanisms responsible for alcohol's effects on sleep.
We have previously shown that acute alcohol exposure causes an increase in extracellular adenosine (AD) in the basal forebrain (BF) region. Increased extracellular AD acts via A1 receptor to inhibit wake-promoting neurons in the BF resulting in NREM sleep promotion (Sharma et al. 2010a,b; Thakkar et al. 2010b) . Although the BF consist of several neuronal subtypes, it is the BF cholinergic neurons that are believed to play an important role in homeostatic regulation of sleep (Kalinchuk et al. 2006 (Kalinchuk et al. , 2008 Porkka-Heiskanen 2013) . Therefore, in this study we focused our attention on understanding the role of BF cholinergic neurons in sleep promotion following acute alcohol exposure. We hypothesized that the BF cholinergic neurons may play an important role in sleep promoting effects of alcohol.
Methods

Experimental design
All experiments were performed according to the Association for Assessment and Accreditation of Laboratory Animal Care policies and Guide for the Care and Use of Laboratory Animals. All protocols were approved by the local committees (MU IACUC #8518). All control and experimental protocols were performed in parallel. All experiments were performed/repeated at least three times.
We designed two experiments to test our hypothesis: Experiment 1 used between-group design [two groups: lesion and sham lesion (controls)] and examined the effects of selective BF cholinergic neuronal lesions on sleep promotion following acute alcohol exposure.
Experiment 2 used within-group design [lesion (ipsilateral BF) and sham lesion (controls; contralateral BF) in the same animal] and examined the effects of cholinergic neuronal lesions on alcohol induced adenosine release in the BF.
A priori power statistical power, effect and sample size calculations were performed by [G*power (Faul et al. 2007 ) a = 0.05; power > 0.8] based on our previous studies (Sharma et al. , 2014b Thakkar et al. 2010b) and preliminary results of this study. The results obtained suggested a sample size of N = 8/group for Experiment 1; N = 4 for Experiment 2.
Exclusion criteria for removal of animals from the experiment and/or from data analysis included removal of head post; unreadable electrographic recordings (electroencephalogram, EEG and/or electromyogram, EMG); incorrect placement of microinjections and/or microdialysis probe (as verified by histology/ immunohistochemistry.
Materials
Animals Adult male Sprague-Dawley rats (300-400 g) were obtained (Charles River, Wilmington, MA, USA) and housed in the animal facility under 12 : 12 h light dark cycle with ambient room temperature (25°C) and ad libitum access to food and water. They were allowed to acclimatize with these conditions for at least 7 days before subjecting them to surgical procedures.
Chemicals and drugs
Alcohol (ethanol, 200 proof) was purchased from Fisher Scientific (Pittsburgh, PA, USA). Artificial cerebrospinal fluid (147 mM NaCl, 3 mM, KCl, 1.2 mM CaCl 2 and 1.0 mM MgCl 2; pH = 7.0) was prepared fresh on the day of the experiment, filtered and used. All salts used for the preparation of artificial cerebrospinal fluid were purchased from Fisher Scientific, (Pittsburgh). , purchased from Advanced Targeting Systems (#IT-01), to lesion the cholinergic neurons of the BF (Blanco-Centurion et al. 2007; Kalinchuk et al. 2008 Kalinchuk et al. , 2015 . 192-SAP was reconstituted as per vendor's instructions, aliquoted and stored at À20°C. The working solution was prepared fresh on the day of the experiment by 1 : 2 dilution with 0.9% saline.
Experiment 1: Effects of selective BF cholinergic neuronal lesions on sleep promotion following acute alcohol exposure Surgery. Using standard surgical procedure and under inhalation anesthesia (1.5% isoflurane), rats were implanted with sleep recording electrodes and bilateral guide cannula in the BF as described previously . Briefly, two screw electrodes to record brain activity (EEG) and wire electrodes to record muscle activity (EMG). In addition, two stainless steel intracerebral guide cannulas (23 gauge) were implanted bilaterally above the target site in the BF [co-ordinates AP À0.3, ML AE 2.5, DV À8.5 relative to bregma (Paxinos and Watson 2007) ] as described previously . EEG and EMG electrodes were connected to a multi-channel electrode pedestal (MS363, PlasticsOne; Roanoke, VA, USA). The entire assembly was secured onto the skull with dental cement. Finally, stylets were inserted into the guide cannula to maintain patency. Flunixin (1.5 mg/kg; post-surgical analgesic) was administered subcutaneously and animals were closely monitored until ambulatory. Subsequently rats were housed singly in the sleep recording cage and allowed to recover from surgical stress.
Habituation. After 1 day of post-operative recovery, rats were tethered to a swivel (Model SL6C, PlasticsOne) via a lightweight recording cable (Model 363-SL/6, PlasticsOne) that minimally interfered with animal movements, and habituated to the recording setup and intragastric administration (ig) for at least 6 days (Thakkar et al. 2010a,b) . Habituation to the recording setup and ig administration was verified by recording sleep-wakefulness cycle continuously for 48 h. Once stable sleep-wake cycle (compared with established sleep-wake cycle in our laboratory) was established, the experiment was begun.
Pre-lesion alcohol administration and verification of alcoholinduced sleep promotion. At dark onset, rats were disconnected from the recording setup, weighed and water (10 mL/Kg) was administered at dark onset. On completion, rats were reconnected to the recording setup and sleep-wakefulness was recorded for 12 h of the dark period. Same protocol was repeated on the following day except that alcohol [35% (v/v in water); 3 g/Kg, ig] was administered. Sleep-wakefulness was recorded for 12 h of dark period.
Basal forebrain cholinergic neuronal lesion. On the following day, rats were randomly divided into two groups: Control and Lesion (Table 1 ). The controls were microinjected with 0.9% saline (500 nL/side) bilaterally into the BF; rats in the lesion group were microinjected with 192-SAP (0.3 lg/500 nL/side). Microinjection protocol used was as described previously Sharma et al. 2014b Sharma et al. , 2015 . On completion, rats were left undisturbed for 18 days to allow for maximal lesions of cholinergic neurons to occur (Kalinchuk et al. 2008) .
Post-lesion habituation and alcohol administration. Next, rats were again exposed to 6 days of habituation as described above. Subsequently, water (10 mL/Kg) and alcohol (3 g/Kg) were administered to all rats (controls and lesioned) at dark onset on subsequent days as described for pre-lesion administration. Sleep-wakefulness was recorded for 12 h of dark period after each treatment. On completion, animals were killed to localize lesion sites in the BF.
Electrographic recording of sleep-wakefulness. The EEG (1-100 Hz) and EMG (30-300 Hz) signals were recorded differentially from bilateral electrodes, amplified (Model 15LT bipolar Physiodata Amplifier System, Grass Technologies, West Warwick, RI, USA), digitized and acquired (128 Hz⁄ channel) by Spike2 software (CED, Cambridge, UK) and stored in Dell Desktop computer.
Sleep-wakefulness analysis. An experimenter, blind to the experimental conditions, visually scored acquired data into 10 s epochs (SleepSigns version 3; Kissei Comtec Co. Ltd., Nagano, Japan) and separated it into three states of behavior: Wakefulness (active and quiet), NREM sleep and rapid eye movement (REM) sleep. The state of wakefulness was identified by the simultaneous presence of desynchronized (fast) EEG and high or reduced EMG tone. NREM sleep was identified by the presence of synchronized slow wave activity in the EEG along with reduced EMG. REM sleep was identified by the concomitant presence of desynchronized EEG and absence of muscle tone. The amount of time spent in wakefulness, NREM, and REM sleep was scored for 12 h dark period and reported as percent time spent in each state of behavior. Sleep onset latency [amount of time in minutes after alcohol administration and first non-interrupted 60 s bout of NREM sleep ] was also calculated. EEG spectral analysis was performed to examine NREM delta power (1-4 Hz). Interanimal variability was controlled by normalizing NREM delta power to obtained relative NREM delta power [NREM delta power/ total power (1-20 Hz)] .
Euthanasia, histology, and Choline acetyltransferase (ChAT) immunohistochemistry. Euthanasia, histology, and choline acetyltransferase (ChAT) immunohistochemistry (IH) was performed as described previously .
Cell counting and analysis. Manual counting of ChAT immunoreactive (ChAT+ve; brown cytoplasm) neurons in the horizontal diagonal band/magnocellularis preoptic/substantia innominata [horizontal diagonal band (HDB)/magnocellularis preoptic (MCPO)/substantia innominata (SI)] region was performed by two blinded investigators (without knowledge of experimental conditions) as previously described Thakkar et al. 2010b) . In brief, four sections/ rat were selected (~100 lm apart) for counting at the levels between AP = 0.0 and AP =À0.40 mm (relative to the bregma). All single labeled ChAT +ve neurons were counted from HDB/SI/MCPO regions .
Statistical analysis. All statistical analysis was performed with Graphpad Prism (San Diego, CA, USA) software. Pre-lesion sleep promoting effects of alcohol were verified by paired t-test. Two-way repeated measures analysis of variance (RM-ANOVA) with treatment (2 levels, water and alcohol) as within subject repeated measures and lesions (2 levels; control, and lesion) as between subject variables followed by Bonferroni's post hoc test was performed to examine the effects of cholinergic BF lesion on alcohol-induced sleep promotion. Unpaired t-test was used to examine the extent of cholinergic neuronal loss in the BF. Level of significance (a) = 0.05.
Experiment 2: Effects of selective BF cholinergic neuronal lesions on alcohol-induced increase in extracellular adenosine in the BF Surgery and basal forebrain cholinergic neuronal lesions. Standard stereotaxic surgical procedures and inhalation anesthesia was used to microinject 192-SAP into ipsilateral BF and saline into the contralateral BF (co-ordinates as described in Experiment 1). The side of the 192-SAP was counterbalanced to avoid any side (left or right) effects. On completion of the microinjections, bilateral microdialysis guide cannulas (Eicom Inc, San Diego, CA, USA) were implanted at the same sites, along with two anchor screws and a dummy multichannel pedestal (MS363, PlasticsOne), and the entire assembly was secured to the brain with dental cement. On completion, stylets were inserted into the guides. Flunixin (1.5 mg/ kg) was administered subcutaneously and animals were closely monitored until ambulatory. Subsequently the rats were singly housed and left undisturbed for 21 days for lesions to occur.
Infusion of alcohol and microdialysis sampling. Next, microdialysis probes (CX-1-8-02, 2 mm membrane length, 0.22 mm O.D; Eicom) were inserted bilaterally in both guide cannulas as previously described (Thakkar et al. 2003b; Sharma et al. 2010b Sharma et al. , 2014b . After connecting microdialysis inline and outline to the probe, the flow through the probe was verified. Next, inline was connected to a microdialysis pump (Model KDS250, KD Scientific Holliston, MA, USA); the outline was connected to a collection vial. Subsequently, artificial cerebrospinal fluid perfusion was begun with a flow rate @ 0.7 lL/min. After allowing at least 7-8 h of probe insertion recovery and for equilibrium at the probe tip, the Animal # 602 was excluded from the experiment due to unreadable EEG recordings. The remaining 15 animals (7 controls and 8 lesion) were used in three batches. While the rats in the lesion group received 192-SAP (0.3 lg/500 nL/side), bilaterally in the basal forebrain (BF), controls were microinjected with 0.9% saline (500 nL/side).
experiment was begun at dark onset and 2 9 40 min (28 lL/sample) pre-ethanol baseline samples were collected from both probes to verify presence of adenosine in the microdialysate. Subsequently, 300 mM dose of ethanol were perfused for 120 min and 3 9 40 min samples were collected, stored in ice until analyzed. Measurement of Extracellular Adenosine. Adenosine separation and quantification was performed by high performance liquid chromatography (HPLC) coupled with UV detector, using the principle of liquid chromatography as described previously (PorkkaHeiskanen et al. 1997; Sharma et al. 2010a Sharma et al. ,b, 2014b . A 10 lL of microdialysis sample were injected into the HPLC and carried through mobile phase (8 mM NaH 2 PO 4 containing 12% methanol, pH = 4) at a flow rate of 0.5 mL/min. Adenosine was separated out with a column (Inertsil ODS-4, 3 micron, 150 9 2.1 mm, GL Sciences Inc., Torrance, CA, USA), and detected by a UV detector (Model SPD20, Shimadzu Scientific Instruments, Columbia, MD, USA) at 258 nm wavelength. Chromatogram data was acquired and analyzed by PowerChrom 280 system (eDAQ Inc., Colorado Springs, CO, USA). Adenosine peak in the sample was identified and quantified by comparing its retention time and area under the peak to pure known amounts of external adenosine standards (Sigma, St. Louis MO, USA). On completion, the animals were killed, brain removed and processed for ChAT IH to verify the lesioning of ChAT +ve neurons as described above. In addition, the selectivity of 192-SAP in lesioning of ChAT +ve neurons was verified by performing parvalbumin IH in the BF (1 : 800 antiparvalbumin antibody, MAB1572, Millipore, Billerica, MA, USA).
Statistical analysis. Paired T-test (Graphpad Prism) was used to examine the (i) extent of cholinergic neuronal loss on the ipsilateral lesion side, as compared to contralateral sham-lesioned control side in the same animal, and (ii) effect of cholinergic neuronal lesion on alcohol induced AD release. a = 0.05.
Results
Experiment 1: Effect of BF cholinergic neuronal lesion on sleep promotion following acute alcohol exposure We began with 16 rats. One was discarded due to noisy EEG recording. The results obtained from 15 rats are as follows:
Pre-lesion verification of alcohol-induced sleep promotion A robust sleep promoting effect of acute alcohol administration is described in Fig. 1 . Sleep onset latency was significantly (t = 4.2; df =14; p < 0.001; paired t-test) reduced (Panel a); percent time spent in NREM sleep was significantly (t = 6.5; df =14; p < 0.0001; Panel b) increased and NREM delta power were significantly increased (t = 2.4; df =14; p < 0.05; Panel c). While percent time spent in wakefulness was significantly reduced (t = 6.4; df = 14; p < 0.0001), REM sleep remained unaffected (t = 1.3; df = 14; p = 0.2; Panel b). The temporal effects of alcohol on sleep-wakefulness and NREM delta activity are described in Fig. 2 . Figure 3a Effects of cholinergic neuronal lesions on alcohol-induced sleep promotion BF cholinergic neuronal lesions attenuated alcohol induced sleep promotion (Fig. 4) .
Extent of cholinergic neuronal loss in the BF
Sleep onset latency. Two-way RM-ANOVA analysis revealed a significant main effect of treatment [F(1, 13) = 7.7; p < 0.01] and lesion [F(1, 13) = 7.5; p < 0.05] without any significant interaction [F(1, 13) = 2.7]. Subsequent Bonferroni post-hoc analysis revealed that sleep onset latency was significantly (p < 0.05) reduced following acute alcohol administration in controls as compared with water treatment. However, in lesioned rats, sleep onset latency following water and alcohol treatment was comparable (Fig. 4a) .
NREM sleep. Two-way RM-ANOVA indicated a significant main effect of lesion [F(1, 13) = 16.6; p < 0.01], treatment [F(1, 13) = 12.0; p < 0.01] and interaction [F(1, 13) = 12.5; p < 0.01] on the amount of time spent in NREM sleep. Bonferroni's post-hoc test revealed that rats in the control group displayed a significant (p < 0.001) increase in NREM sleep following alcohol administration as compared to water treatment. In contrast, no such increase was observed in lesioned rats and the amount of time spent in NREM sleep was comparable after alcohol and water treatment (Fig. 4b) .
Wakefulness. Two-way RM-ANOVA indicated a significant main effect of lesion [F(1, 13) = 15.2; p < 0.01], treatment [F(1, 13) = 13.8; p < 0.01], and interaction [F(1, 13) = 8.6; p < 0.05] on the amount of time spent in wakefulness (Fig. 4c) . In control rats, as compared with water administration, alcohol treatment caused a significant reduction (p < 0.01; Bonferroni's) in wakefulness. However, the amount of time spent in wakefulness was comparable after water and alcohol treatment in rats with BF cholinergic neuronal lesions (Fig. 4c) .
REM sleep. No significant effect of lesion [F(1, 13) = 3.5], treatment [F(1, 13) = 3.7], or interaction [F(1, 13) = 0.0] was observed on REM sleep (Fig. 4d) .
NREM delta power. The BF cholinergic lesions had no effect on lesion [F(1, 13) = 2.3], treatment [F(1, 13) = 0.0] and interaction [F(1, 13) = 2.1] on NREM delta power (Fig. 4e ).
Experiment 2: Effects of selective BF cholinergic neuronal lesions on alcohol induced extracellular adenosine release in the BF
Extent of cholinergic neuronal loss in the BF Local infusion of 192-SAP produced selective and specific effects on lesioning of ChAT +ve cholinergic neurons in the HDB/SI/MCPO region on the side of the injection, without affecting parvalbumin +ve neurons in the HDB/SI/MCPO region (Fig. 5a-c) and ChAT+ve neurons in other nuclei ( Fig. 5d and e) .
As compared to ChAT +ve neurons on the sham-lesioned side (control side; injected with saline; Mean AE SEM = 264 AE 35.6; N = 4), the side that received 192-SAP displayed a significant reduction (t = 4.5, df = 3, p < 0.05, paired t-test) in ChAT +ve neurons (Mean AE SEM = 95 AE 15.2; Fig. 6a-d) .
AD release
Pre-alcohol baseline AD levels (Mean AE SEM; N = 4) were as follow: Control side = 39.6 AE 6.3; Lesion side = 40.3 AE 4.2. There was a significant (t = 11.6, df = 3, p < 0.001, paired t-test) reduction in AD release following local infusion of 300 mM alcohol in the lesion side as compared with the control side (Fig. 6e) . The inset in Fig. 6e describes the chromatograms of pure AD (standard; 50 nmol/L), AD collected from control and lesioned sides of the BF during 300 mM alcohol perfusion.
Discussion
The major findings of this study are that lesions of the BF cholinergic neurons attenuated (i) alcohol induced sleep promotion and (ii) alcohol induced-AD release in the BF. Based on these results, we suggest that the cholinergic neurons of the BF have an important role in sleepiness that is observed after alcohol consumption.
The BF region is comprised of the vertical & horizontal limbs of diagonal band of Broca, substantia innominata and magnocellularis preoptic region (Kimura et al. 1980; Mesulam et al. 1983) . Although multiple neuronal subtypes are present in the BF, electrophysiological indicators of sleep homeostasis, including sleep deprivation induced increase in AD release, delta activity and recovery sleep, are severely disrupted following 192-SAP lesions of BF cholinergic neurons (Gritti et al. 1997; Kalinchuk et al. 2006 Kalinchuk et al. , 2008 Kalinchuk et al. , 2015 Jones 2008; Porkka-Heiskanen 2013) . Since we have previously observed that alcohol mediates its sleep-promoting effect by inhibiting the BF region , we decided to focus on, and investigate, the role of BF cholinergic neurons in sleep promoting effects of alcohol.
We chose to use 192-SAP, which binds to the p75 nerve growth factor receptor present on the BF cholinergic neurons, to selectively lesion BF cholinergic neurons. This method is Fig. 1 Alcohol administration at dark onset before basal forebrain (BF) cholinergic neuronal lesions resulted in sleep promotion. As compared to water (10 mL/Kg, ig), rats exposed to alcohol (3 g/kg, ig) displayed a significant reduction in sleep onset latency (a), a significant increase in percent time spent in non-rapid eye movement (NREM) sleep (b), and a significant increase in NREM delta power (c). While percent time spent in wakefulness was reduced, REM sleep remained unaffected (b). ***p < 0.001 and *p < 0.05.
Published 2017. This article is a U.S. Government work and is in the public domain in the USA. J. Neurochem. (2017) 142, 710--720 extensively used to selectively lesion BF cholinergic neurons and examine its effects on several behaviors including sleepwakefulness, attention, learning and memory (Bassant et al. 1995; Kapas et al. 1996; Kalinchuk et al. 2008; Kaur et al. 2008; Easton et al. 2011; Ljubojevic et al. 2014) . We chose to perform local infusion of 192-SAP in the BF region to achieve specificity (no effect on BF non-cholinergic neurons see Fig. 5 ) and selectivity (no effect on other cholinergic nuclei in the BF see Fig. 5 ). Our results suggest that local BF infusion of 192-SAP reduced cholinergic neurons by 64%. This is consistent with previous reports (Kalinchuk et al. 2008; Kaur et al. 2008) .
To isolate anatomical substrates/cellular mechanisms involved in alcohol-induced sleep, it is essential to perform the experiment when sleep is minimal, and to expose all sleep-wake centers to alcohol. Therefore, we performed our experiments during the active/dark period when rats spent majority of time (> 70%) in wakefulness ) and chose to use systemic administration of alcohol.
Our first experiment was designed to examine the effects of BF cholinergic lesion on sleep promotion following acute alcohol exposure. Alcohol was administered via ig route because laboratory rats do not readily consume alcohol. The ig route of administration offers several advantages including minimal involvement of pain. In addition, this method is similar to the route used by humans to consume alcohol. In contrast, pain is inherent with intraperitoneal route of alcohol administration. The 3 g/kg dose of alcohol was chosen because this dose is effective in promoting sleep and activating the reward centers AlauxCantin et al. 2013; Sharma et al. 2014a ). The sleep promoting effects of alcohol was confirmed pre-lesion.
Lesions of the BF cholinergic neurons suppressed alcohol induced sleep promotion. Control (sham lesion) rats displayed a robust sleep promotion following alcohol administration as evidenced by a profound reduction (> 70%) in sleep onset latency along with an (> 30%) increase in the time spent in NREM sleep. In contrast, no such alcoholinduced sleep promotion was observed in rats with BF lesions. Similarly, while alcohol suppressed wakefulness in sham-lesioned controls, alcohol had no effect on wakefulness in lesioned rats. REM sleep was minimally affected. Interestingly NREM delta activity, a measure of sleep quality, was not reduced suggesting that other neuronal subtypes within the BF or sleep active neurons in the median preoptic and/or ventrolateral preoptic regions may contribute toward maintaining delta activity following alcohol administration in the lesioned animals. Based on the results of this experiment, we suggest that the BF cholinergic neurons are the mediators of alcohol-induced sleep promotion. Alcohol administration did not have any effect on REM sleep both in controls as well as in lesioned animals. The effects of cholinergic neuronal lesion on NREM delta activity is described in (e). Alcohol administration did not have any effect on NREM sleep delta activity in controls and lesioned animals *p < 0.05, and ***p < 0.001.
Our second experiment was designed to understand the mechanism of attenuation of alcohol induced sleep by BF cholinergic neuronal lesion. We had previously observed that adenosine in the BF might have a key role in sleep promotion following acute alcohol consumption Thakkar et al. 2010b) . Therefore, we examined the effects of BF cholinergic neuronal lesions on alcohol induced adenosine release in the BF. With-in group design, with sham lesion (controls) on ipsilateral side and BF cholinergic lesion on contralateral side, was used to achieve robust statistical power and eliminate between-group variabilities. Alcohol metabolism in the periphery can have an indirect effect on adenosine levels in the brain. To avoid this confound, alcohol was delivered directly into the BF. Reverse microdialysis was used for local delivery of alcohol because it allows for measuring neurotransmitter release while delivering low and constant concentrations of drugs with precise control in specific brain regions and with minimal neurotoxic damage (Quan and Blatteis 1989; Thakkar et al. 1998 Thakkar et al. , 2003a Ericson et al. 2003; Lof et al. 2007; Sharma et al. 2010b) . The experiment was conducted during the initial hours of the dark period when spontaneous adenosine levels are lowest and rats are maximally awake (Murillo-Rodriguez et al. 2004) . This avoids sleep deprivation, which can be a confounding variable. Microdialysis perfusion of 300 mM dose of alcohol was chosen based on previous studies conducted by our laboratory and others (Ericson et al. 2003; Sharma et al. 2010b Sharma et al. , 2014b . This dose of alcohol results in an effective concentration of alcohol (near the probe site in the BF), which is not toxic, but it is in the range of alcohol concentration observed in the brain after a systemic administration of the sleep promoting (> 2 g/kg) dose of alcohol (Yoshimoto and Komura 1993; Ericson et al. 2003; Sharma et al. 2010b) . The HPLC-UV detection method used for adenosine measurements from microdialysate sample has been verified and previously used by our laboratory and others (Porkka-Heiskanen et al. 1997; Murillo-Rodriguez et al. 2004; Blanco-Centurion et al. 2006; Sharma et al. 2010a,b) . Our adenosine assay was highly sensitive with a detection limit of 500 fmoles.
The results of our second experiment suggest that BF cholinergic neuronal lesion caused a marked reduction (> 50%) in alcohol induced adenosine release in the BF. Since alcohol increases extracellular adenosine by inhibiting equilibrative nucleoside transporter-1 and blocking adenosine reuptake , these results suggest that the BF cholinergic neurons may be a major source of alcohol-induced increase in extracellular adenosine.
Recent studies suggested that ATP has a critical role in sleep-wakefulness and may contribute to extracellular adenosine and the homeostatic control of NREM sleep (Dworak et al. 2010; Kim et al. 2015) . Does alcohol-ATP interaction contribute towards adenosine release and/or sleep promotion? This is an interesting, yet unanswered question, which will be addressed in our future studies. One limitation of our study is that we lesioned only one brain center to examine sleep-promoting effects of alcohol. Further studies will addressed the importance of other sleepwake center in sleep promoting effects of alcohol.
In summary, we performed two experiments to examine the neuronal mediators of sleep-promotion following alcohol consumption. Our first experiment examined the effects of BF cholinergic neuronal lesion on sleep promotion following systemic alcohol administration. Our second experiment examined the effects of BF cholinergic neuronal lesions on alcohol-induced increase in extracellular adenosine. The results of our study suggest that loss of cholinergic neurons in the BF attenuates alcohol-induced increase in adenosine and suppresses alcohol-induced sleep promotion. Based on these results, we suggest that alcohol promotes sleep by increasing adenosine via its action of the BF cholinergic neurons.
In conclusion, based on the results of this study, we suggest that the BF cholinergic neurons have an important role in alcohol-induced sleep promotion. (e) described the effects of local alcohol (300 mM) infusion (reverse microdialysis) on AD release in the BF. Significant reduction was observed on the lesion side as compared with the control side. The chromatograms of pure AD (50 nmol/L; indicated by red arrow) standard, AD collected from control and lesioned sides during 300 mM alcohol perfusion in the BF is depicted in the inset in (e). **p < 0.01.
